To compare the efficacy of fingolimod and natalizumab in preventing regional grey matter (GM) and white matter (WM) atrophy in relapsing-remitting multiple sclerosis (RRMS) over 2 years.
Two-year regional grey and white matter volume changes with natalizumab and fingolimod / Preziosa, P., Rocca, M.A., Pagani, E., Storelli, L., Rodegher, M., Moiola, L., Filippi, M.. - In: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. - ISSN 0022-3050. - 91:5(2020), pp. 493-502. [10.1136/jnnp-2019-322439]
Two-year regional grey and white matter volume changes with natalizumab and fingolimod
Preziosa, Paolo;Rocca, Maria A;Filippi, Massimo
2020-01-01
Abstract
To compare the efficacy of fingolimod and natalizumab in preventing regional grey matter (GM) and white matter (WM) atrophy in relapsing-remitting multiple sclerosis (RRMS) over 2 years.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
JNNP 91_493.pdf
solo gestori archivio
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Tutti i diritti riservati
Dimensione
1.98 MB
Formato
Adobe PDF
|
1.98 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
